![](https://msfsouthasia.org/wp-content/uploads/2022/10/MSB120839_Medium-1.jpg)
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
July 17, 2024Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without...
Read more![](https://msfsouthasia.org/wp-content/uploads/2024/06/TB_SA_geneXpert__2011_JoseCendon_MSF28750_3500pxOriginal_3.jpg)
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
June 18, 2024Geneva, 17 June 2024 - In September 2023, the US corporation Danaher, which owns diagnostics maker Cepheid, announced a price reduction of the primary GeneXpert test used to diagnose tuberculosis (TB), from US$9.98 to $7.97, amid pressure from TB activists....
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/05/flag-scaled.jpeg)
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
June 7, 2024Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...
Read more![](https://msfsouthasia.org/wp-content/uploads/2024/06/MSB185529.jpg)
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
June 4, 2024Where are we now? This week, on 6-7 June 2024, the Board of Gavi, the Vaccine Alliance, is meeting in Geneva to approve and endorse the one-page framework for Gavi 6.0, which outlines its strategy for the five-year period from...
Read more![](https://msfsouthasia.org/wp-content/uploads/2024/02/Untitled-design-14.jpg)
MSF welcomes Indian government standing strong against EFTA trade deal’s harmful intellectual property provisions
February 15, 2024Geneva/New Delhi, 15 February 2024 — In a welcome move today, the Indian Commerce Ministry confirmed its rejection of Switzerland's demand for data exclusivity for medicines in the India-EFTA trade deal, and emphasised the importance of protecting the country’s generic...
Read more![](https://msfsouthasia.org/wp-content/uploads/2024/02/Untitled-design-12.jpg)
Millions of peoples’ access to affordable medicines at risk if India-EFTA trade deal finalised as is
February 14, 2024Text leaked yesterday shows India-EFTA trade deal includes excessive intellectual property provisions that may require India to gut pro-public health national laws.Geneva/New Delhi, 14 February 2024 — Following news that India and the European Free Trade Association (EFTA) – which...
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/11/tb_india_childpatient_2023_siddharthsingh_msb178886_3800px.jpg)
MSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/09/tb_ny_protest_2020_neginallamehzadeh_msf302304_2000px.jpg.jpg)
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
September 30, 202330 September 2023, Geneva Christophe Perrin, TB Advocacy Pharmacist, MSF Access Campaign: “We welcome Johnson & Johnson’s (J&J) announcement finally paving the way for unfettered access to affordable generic versions of bedaquiline for all people living with drug-resistant tuberculosis (DR-TB) who need...
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/07/mozambique-scaled-1.jpg)
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
July 25, 2023Nampula, July 21 , 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) is collaborating with the District Services of Health, Women and Social Action in Mogovolas and the Provincial Services in Nampula, Mozambique, to deliver surgical treatment for hydrocele, one...
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/04/Ft-g9LEXoAMJ02N.jpg)
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
July 19, 2023Gavi should waive co-financing requirements for countries with fragile health systems or in humanitarian crises.Geneva, 18 July, 2023 — Today, Médecins Sans Frontières/Doctors Without Borders (MSF) again called on Gavi, the Vaccine Alliance to broaden “catch-up” vaccine coverage for unprotected...
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/07/JJ-scaled-1.jpg)
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
July 18, 2023MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...
Read more![](https://msfsouthasia.org/wp-content/uploads/2023/07/delta-amaruco-pr-cover-scaled-1.jpg)
Shortening distances: providing healthcare to indigenous communities in Venezuela’s Delta Amacuro state
July 18, 2023Rivers serve as roads and tropical rainforest stretches to the horizon in Delta Amacuro state, a vast area bordering the Atlantic Ocean in northeastern Venezuela. Largely inaccessible, this region is home to a large number of Indigenous communities who face...
Read more